Abstract

We have shown recently that the immunophilins CyP-40 and FKBP52/hsp56 bind to a common site on hsp90 and that they exist in separate heterocomplexes with the glucocorticoid receptor (GR). FKBP52/hsp56 binds to hsp90 via its tetratricopeptide repeat (TPR) domains, it is not required for GR.hsp90 heterocomplex assembly, and it is thought to play a role in targeted movement of the GR. In this work we examine the hsp90 binding of four proteins (FKBP52/hsp56, CyP-40, p50, Mas70p) thought to be involved in targeted protein trafficking. FKBP52/hsp56 and CyP-40 (each with three TPRs), localize to the nucleus and nucleoli, respectively, and form relatively weak complexes with hsp90 that are competed by a CyP-40 fragment containing its three TPRs. The p50 component of the Src.hsp90 and Raf.hsp90 heterocomplexes localizes to cytoskeletal fibers extending from the perinuclear region to the plasma membrane and forming a rim under the plasma membrane of endothelial cells. p50, Mas70p (seven TPRs), which is a receptor for mitochondrial import, and the p60 (six to eight TPRs) component of the steroid receptor.hsp90 heterocomplex assembly system bind very tightly to hsp90 in a manner that is not competed by the CyP-40 fragment. However, bacterially expressed p60 blocks the binding of p50, Mas70p, FKBP52/hsp56, and CyP-40 to purified hsp90. The data are consistent with binding of all of these proteins to a site on hsp90 that is a general TPR domain acceptor. Our localization and binding data are used to develop a model in which proteins that are chaperoned by hsp90 move as dynamic complexes to their cellular sites of action, with the TPR-containing protein participating in targeting the movement of the complexes.

Highlights

  • Little is known about how proteins that are not conveyed by a vesicle-based protein trafficking system move through the cytoplasm to arrive at their sites of action in organelles, such as the nucleus or mitochondria, or at a cellular locus like the

  • We have shown recently that the immunophilins CyP-40 and FKBP52/hsp56 bind to a common site on hsp90 and that they exist in separate heterocomplexes with the glucocorticoid receptor (GR)

  • In 1992, we proposed that the receptors shuttle through the cytoplasm in the heterocomplex form, with hsp90 and the immunophilin acting as a protein transport unit or transportosome [15]

Read more

Summary

EXPERIMENTAL PROCEDURES

Untreated rabbit reticulocyte lysate was from Green Hectares (Oregon, WI). 125I-Conjugated goat anti-mouse and anti-rabbit IgGs were from DuPont NEN. 125I-Conjugated goat anti-mouse and anti-rabbit IgGs were from DuPont NEN. Trypsin, powdered Dulbecco’s modified Eagle’s medium (high glucose), goat anti-mouse IgG-horseradish peroxidase conjugate, monoclonal nonimmune IgG and IgM, nonimmune rabbit serum, TUB2.1 monoclonal anti-␤-tubulin IgG, antinucleolar antibody (nucleolar positive control) and the fluorescein isothiocyanate (FITC)-conjugated antihuman IgG were from Sigma. Goat anti-mouse IgM, donkey anti-rabbit IgG-horseradish peroxidase conjugate, and protein A-agarose were from Pierce. The anti-cyclophilin 40 (COOH-terminal peptide) antibody and the 3G3 monoclonal anti-hsp IgM were from Affinity BioReagents (Golden, CO). FITC-conjugated donkey anti-mouse IgG and IgM and rhodamine-conjugated donkey anti-rabbit IgG were from Jackson ImmunoResearch Laboratories (West Grove, PA). The UPJ56 rabbit antiserum against FKBP52/hsp56 [58] was a gift from Drs Karen Leach and Martin Deibel (The Upjohn Co.). 4059 is a bacterially expressed human CyP-40 COOH-terminal fragment containing the FKBP52-like TPR domain, but not the CyP-18-like domain, and it was purified by Ni2ϩ affinity chromatography and thrombin cleavage.

Methods
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.